Genmab
GMAB
$27.94
Share price
-0.69%
Change (1 day)
-28.39%
Change (1 year)
Categories
Earnings for Genmab (GMAB)
Earnings in 2024 (TTM): C$1.82 Billion
According to Genmab's latest financial reports the company's current earnings are C$3.10 Billion. , an increase over its 2023 earnings that were of C$1.11 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Genmab from 2009 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | C$1.82 B | 63.99% |
| 2023 | C$1.11 B | -17.29% |
| 2022 | C$1.34 B | 55.87% |
| 2021 | C$0.86 B | -31.09% |
| 2020 | C$1.25 B | 111.51% |
| 2019 | C$0.59 B | 69.44% |
| 2018 | C$0.34 B | 49.63% |
| 2017 | C$0.23 B | 3.27% |
| 2016 | C$0.22 B | 46.33% |
| 2015 | C$0.15 B | 117.13% |
| 2014 | C$71.17 M | 329.17% |
| 2013 | C$16.58 M | -159.26% |
| 2012 | -C$27.99 Million | -48.96% |
| 2011 | -C$54.84 Million | 90.86% |
| 2010 | -C$28.73 Million | -67.46% |
| 2009 | -C$88.3 Million |